University of Chicago’s Polsky Center for Entrepreneurship has formed microbiome-focused Avnovum Therapeutics, BiomeSense, Covira and Oxalo Therapeutics over the past year.
University of Chicago (UChicago)’s Polsky Center for Entrepreneurship has highlighted the founding of four US-based biotech spinouts focused on microbiome-based applications over the past year. The companies include Avnovum Therapeutics, which is working on microbial peptides that help vitalise fungal microbiomes by preventing infection and virulence, and BiomeSense, which is developing an automated sensor that evaluates…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
